Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
2020 · Scientific Reports · 55 citations
https://doi.org/10.1038/s41598-020-59711-y
L
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
150
Papers
3.2K
Citations
28
h-index
59
i10-index
Li Ou is an academic researcher from Research Institute of Petroleum Exploration and Development. The author has contributed to research in topics: Nuclear physics research studies & HIV Research and Treatment & Immune Cell Function and Interaction. The author has an h-index of 28, co-authored 128 publications.
ORCID: 0000-0001-5653-8684Papers by this author
worksEffect of the splitting of the neutron and proton effective masses on the nuclear symmetry energy at finite temperatures
2011 · Physics Letters B · 26 citations
https://doi.org/10.1016/j.physletb.2011.01.062
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
2020 · Cell Reports · 25 citations
https://doi.org/10.1016/j.celrep.2020.107981
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
2024 · Cell · 25 citations
https://doi.org/10.1016/j.cell.2024.10.003
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B
2025 · Nature Microbiology · 8 citations
https://doi.org/10.1038/s41564-025-02153-x
Tryptophan-like side chain holding aptamers inhibit respiratory syncytial virus infection of lung epithelial cells
2023 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-023-36428-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat